Rocky Mountain Pediatric Endocrinology, PC

United Statesrmpedendo.com

Rocky Mountain Endocrinology is a private medical practice specializing in pediatric endocrinology. It provides comprehensive diagnosis and treatment for a range of hormone-related disorders in children, including growth disorders, puberty issues, thyroid gland conditions, adrenal disorders, calcium metabolism problems, and metabolic bone diseases. The practice does not manage diabetes patients and focuses exclusively on endocrine conditions.

Read more

Founded in 2013 by pediatric endocrinologist Dr. Aristides Maniatis in the Denver metropolitan area of Colorado, the clinic operates from its primary location in Centennial with additional sites serving the region. It offers outpatient care and inpatient consultations at Rocky Mountain Hospital for Children. The practice is actively engaged in clinical research, participating in multiple phase 3 and phase 4 trials related to long-acting growth hormone therapies and other endocrine conditions, and serves as a site for investigators in studies such as the REAL8 trial.

In partnership with the Colorado Department of Public Health since 2016, it provides initial consultations for newborns in Colorado and Wyoming with abnormal screens for congenital hypothyroidism. As a small, physician-owned private practice, it emphasizes specialized, patient-centered care, medical education, and contributions to the field through publications and lectures by its founder, who is recognized as an international key opinion leader in growth disorders.

Also known as RMPE.

Projects Rocky Mountain Endocrinology is involved in

None yet. When a new project in the record names Rocky Mountain Endocrinology as owner, partner or investor, it shows here.

Active projects close to Rocky Mountain Endocrinology

Rocky Mountain Endocrinology in chemical industry news

20 November 2026
Novo Nordisk wins FDA approval for weekly Sogroya in children with Turner syndrome

In the REAL8 trial, 105 children had comparable growth rates after 52 weeks on weekly somapacitan-beco or daily somatropin.